Announced Mon, 20 Jul · 10:43 IST
Ajanta Pharma board meeting on 30 July 2026 for Q1 results
Results View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.8%1-day move
₹3410.00
prior close
₹3448.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.2+0.3+0.3+4.8+1.2+0.6-1.1-0.7—————
Up moveDown movePending
AI summary
Ajanta Pharma has informed BSE that its Board of Directors will meet on Thursday, 30 July 2026, to consider and approve the unaudited consolidated and standalone financial results for the first quarter ended 30 June 2026. The notice is filed under Regulation 29 of the Listing Regulations.
Likely market impact
Routine regulatory filing. No impact on shareholders; investors should watch for the Q1 results on 30 July.